3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
9
Adenocarcinoma
2
Urologic Diseases
1
Radiation Injuries
1
Oligometastatic Prostate Cancer
1
Neoplasm Recurrence, Local
1
Metastatic Hormone-Sensitive Prostate Cance
1
Gastrointestinal Diseases
1
Erectile Dysfunction
1
Abiraterone Acetate
1
Interventions
Oxaliplatin
4
Capecitabine
3
Radiotherapy
2
Docetaxel
2
Androgen Antagonists
2
tislelizumab
1
pembrolizumab
1
luprolide acetate gel depot
1
lenvatinib
1
enzalutamide
1
cemiplimab
1
Surgical Procedures, Operative
1
Radiotherapy, Image-Guided
1
Poly(ADP-ribose) Polymerase Inhibitors
1
PF06821497
1
Negative-Pressure Wound Therapy
1
Leuprolide
1
Leucovorin
1
Injections
1
Fluorouracil
1
Drug Therapy
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Adenocarcinoma
×
Androgen Antagonists
×
Clear all
NCT07460726
2026-03-10
PRIAPUS-PCa
CancerCare Manitoba
Not yet recruiting
130 enrolled
NCT07268794
2025-12-08
CONVERT-HB1
Fudan University
Phase 2
Not yet recruiting
112 enrolled